Geoff Mulvihill

Latest in Operations
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
August 4, 2022
Fractory Us At Imts
Chicago-Based Business Takes Its Cloud Manufacturing Operations Beyond Midwest
September 30, 2022
Visitors look at cars produced by Geely at the Auto China 2020 show in Beijing on Sept. 27, 2020. Geely Holding Group, one of China's biggest independent automakers, has bought a 7.6% stake in British luxury brand Aston Martin Lagonda and said Friday, Sept. 30, 2022, that it looks forward to potential opportunities to collaborate.
China's Geely Buys 7.6% Stake in Aston Martin Lagonda
September 30, 2022
Swagelok Thumb
Keeping Supply Pressure Effect (SPE) Manageable in Pressure-Reducing Regulators
September 29, 2022
Related Stories
Betsy Berkhemer-Credaire, CEO of 50/50 Women on Boards, in the Tom Bradley Conference Room at City Club LA in downtown Los Angeles, Sept. 3, 2021.
Operations
Report: Women Gained Fewer U.S. Company Board Seats in 2022
eBay former Senior Director of Safety and Security James Baugh arrives for his sentencing in a cyber stalking case at Moakley Federal Court on Thursday, Sept. 29, 2022, in Boston.
Operations
Ex-eBay Execs Get Prison for Bizarre Harassment Scheme
Swagelok Thumb
Operations
Keeping Supply Pressure Effect (SPE) Manageable in Pressure-Reducing Regulators
Industrial Media Unboxing Video
Sponsored
Industrial Media Unboxing Video
More from Geoff Mulvihill
Industrial Media Unboxing Video
Sponsored
Industrial Media Unboxing Video
IEN Unboxed is a new show in which our editors unbox new tools on the market and discuss their features.
August 4, 2022
Fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y., on Aug. 9, 2021. A judge said he is extending legal protections for members of the Sackler family, Wednesday, March 2, 2022, who own OxyContin maker Purdue Pharma by another three weeks to buy time to work out a new settlement to thousands of lawsuits over the opioid crisis.
Regulation
Purdue Pharma, U.S. States Agree to New Opioid Settlement
It could be more than $10 billion.
March 3, 2022
Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., Monday, Aug. 9, 2021. Purdue Pharma's quest to settle thousands of lawsuits over the toll of OxyContin is entering its final phase with the grudging acceptance of most of those with claims against the company.
Regulation
OxyContin Maker's Settlement Goes to Judge for Confirmation
It comes nearly two years after seeking bankruptcy protection.
August 12, 2021
In this Oct. 21, 2020, file photo Purdue Pharma headquarters stands in Stamford, Conn. Purdue Pharma pleaded guilty Tuesday, Nov. 24 to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.
Regulation
OxyContin Maker Pleads Guilty in Criminal Case
Purdue Pharma admitted impeding the U.S. Drug Enforcement Administration's efforts to combat the addiction crisis.
November 24, 2020
A Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A federal bankruptcy judge ruled Tuesday, July 28, 2020 that OxyContin maker Purdue Pharma can't make any more contributions to partisan organizations that seek to boost the election efforts of candidates for state attorney general offices.
Regulation
Judge: Purdue Pharma Must Halt Some Political Contributions
Purdue contributed to attorneys general associations even while negotiating a settlement with states over the opioid crisis.
July 29, 2020
Christina Caldwell, left, of Henry Ford Population Health helps unload supplies with Matt Thatcher, who donated them from the Detroit Golf Club, Wednesday, April 8, 2020, in Detroit. The hospital is also in need of gowns and other PPE items and hopes more donations will be coming in from others to help during the coronavirus pandemic.
Supply Chain
Creative Hunt for Supplies
The federal cupboard is officially bare.
April 10, 2020
In this July 1, 2013 file photo, is the exterior of the Mallinckrodt Pharmaceuticals office in St. Louis.
Operations
Generic Drugmakers Sold Most Opioids During Overdose Crisis
Court documents reveal a company culture that allowed Mallinckrodt to become one of the giants of the prescription opioid market.
February 26, 2020
I Stock 1162845770
Regulation
Drugmaker Reaches $1.6B Opioid Settlement
The deal is intended to end hundreds of lawsuits faced by the company over opioids.
February 25, 2020
This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. OxyContin maker Purdue Pharma launched an ad campaign Monday, Feb. 24, 2020, to tell people harmed by their powerful prescription opioid where they can file claims against the company.
Regulation
Purdue Pharma Starts Claim Campaign
It tells people where they can file claims against the company.
February 24, 2020
This June 17, 2019, file photo shows 5-mg pills of Oxycodone. The judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma will consider Wednesday, Dec. 4, 2019 whether the company's CEO should get a bonus equal to half his $2.6 million salary.
Regulation
Bankruptcy Judge Considers Purdue Pharma CEO's $1.3M Bonus
Purdue says maintaining its bonus program is essential to keep employees on the job and performing.
December 4, 2019
In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company's bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week.
Operations
Purdue Paid CEO $9M Before Bankruptcy
Five other board members overseeing the private company were paid a combined $3.7 million over that span.
October 30, 2019
Summit county executive Ilene Shapiro speaks to the media outside the U.S. Federal courthouse, Monday, Oct. 21, in Cleveland.
Operations
Companies Reach $260M Deal to Settle Opioids Lawsuit
The settlement ends only the suits brought by the Ohio counties of Cuyahoga and Summit.
October 21, 2019
In this Wednesday, Sept. 11, 2019, file photo, narcotics detective Ben Hill, with the Barberton Police Department, shows two bags of medications that are are stored in their headquarters and slated for destruction in Barberton, Ohio. Jury selection is set to begin Wednesday, Oct. 16, 2019, in the first federal trial over the nation's opioid epidemic.
Regulation
Opioid Industry Presses for Settlement
The talks involve the distributors AmerisourceBergen, Cardinal Health and McKesson, as well as drug makers Johnson & Johnson and Teva.
October 17, 2019
In a Nov. 6, 2018 file photo, Dave Yost speaks at the Ohio Republican Party event, in Columbus, Ohio. A federal appeals court has denied an effort by state attorneys general to stop a bellwether opioids trial involving two Ohio counties from getting underway later this month in Cleveland. The Sixth Circuit U.S. Court of Appeals in Cincinnati ruled Thursday, Oct. 10, 2019 that Ohio didn’t object when lawsuits filed by Summit and Cuyahoga counties were initially included in what has become a sprawling case involving around 2,600 local governments and other entities. Yost argued in August against the certification of the local government lawsuits as multi-district litigation.
Operations
Court Denies Attempts to Stop Opioid Trial
The trial for Ohio's Summit and Cuyahoga counties is a closely watched bellwether that could lead to settlements of the suits.
October 10, 2019
In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday, Oct. 4, 2019 blasted the terms of OxyContin maker Purdue Pharma’s offer to settle thousands of lawsuits over the toll of the nation’s opioids crisis.
Operations
True Profits of OxyContin Revealed
Previously, former Purdue CEO Richard Sackler gave only a broad range — between $1 billion and $10 billion — that the family made from its signature painkiller.
October 7, 2019